High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards
NCT ID: NCT06715423
Last Updated: 2025-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
960 participants
OBSERVATIONAL
2025-01-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of High Flow Nasal Cannula Oxygen Therapy in Pediatric Intensive Care Unit
NCT03505814
High Flow Nasal Cannula in Children With Status Asthmaticus
NCT03157102
Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients
NCT04852432
High Flow Nasal Cannula in Preterm Infants
NCT03007056
High Flow Nasal Cannula in Comparison With Nasal Continuous Positive Airway Pressure in the Management of Respiratory Distress Syndrome
NCT02587832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pediactric ICU Hospitalized children 1mo to 5 yo
Prescription of HFNO therapy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* parent consenting to the use of the data
1 Month
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MOH Afghanistan
UNKNOWN
MOH Bangladesh
UNKNOWN
MOH Sierra Leone
UNKNOWN
MOH Yemen
UNKNOWN
MSF Médecins Sans Frontières Belgium
UNKNOWN
MSF Médecins Sans Frontières France
UNKNOWN
Fisher and Paykel Healthcare
INDUSTRY
Epicentre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herat regional Hospital
Herat, , Afghanistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G2429-HFNO_ProcessEvaluation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.